Dublin, July 25, 2025 (GLOBE NEWSWIRE) -- The "Antibody Discovery - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering.
The antibody discovery market, segmented by service type, antibody type, application, source, end-users, and geography, is poised to grow steadily, driven by the rising prevalence of chronic diseases and increasing demand for biological therapies. In 2024, the market was valued at USD 1.79 billion, with expectations to reach USD 3.86 billion by 2032, reflecting a CAGR of 10.12% from 2025 to 2032.
Market dynamics are influenced by the escalating global burden of chronic diseases such as cancer, diabetes, cardiovascular, and neurological disorders. The need for biologics like monoclonal antibodies and cell therapies, which provide targeted treatment, is increasing, thus driving the demand for advanced drug development services. Additionally, biotechnology and pharmaceutical firms' inclination toward outsourcing discovery services to Contract Research Organizations (CROs) to ensure efficient development is further propelling market growth.
Antibody Discovery Market Dynamics:
In 2022, 20 million new cancer cases were reported globally, projected to rise to 32.6 million by 2045. This increasing cancer burden is augmenting the need for biologics due to their specificity and reduced toxicity. Similarly, diabetes prevalence is soaring, with projections of 783 million adults affected by 2045. This trend is fostering a demand for innovative biologics developed through effective antibody discovery services. Furthermore, neurological conditions such as epilepsy and depression also highlight the necessity for biologic-based targeted therapies, advancing market growth.
The demand for biologic drugs, credited to their high efficacy and reduced side effects, is significantly expanding the antibody discovery market. Data from the Association for Accessible Medicines shows over 90% of U.S. prescriptions filled in 2022 were generic or biosimilar, indicating a shift toward cost-effective biologic alternatives.
To contend with market demands, industry leaders are investing in collaborative endeavors and research partnerships. For instance, Alloy Therapeutics Inc. partnered with Pfizer Inc. in 2025 to develop a platform aimed at enhancing Pfizer's antibody discovery capabilities. Yet, challenges in development processes, manufacturing complexities, and high production costs are potential constraints on market growth.
Antibody Discovery Market Segment Analysis:
In 2024, the antibody engineering & optimization category is projected to dominate. This growth is driven by the need for biologic drugs where antibody engineering enhances therapeutic efficacy and safety. The modification processes, such as improving binding affinity, molecular stability, and production scalability, are vital for commercial success.
North America Dominance:
North America is anticipated to lead the antibody discovery market, benefiting from substantial R&D investments, a high prevalence of chronic diseases, increasing demand for biologic treatments, and a robust pipeline of drug development activities. The U.S. alone had 2.38 million new cancer cases in 2022, with growth projections to 2030 indicating a significant disease burden.
Additionally, the increasing incidence of diabetes and heart disease in North America is creating demand for innovative, targeted therapies. In 2022, 6.2 million adults in the U.S. were recorded with heart failure, further driving the need for antibody discovery services.
Key Market Players:
Notable companies in the antibody discovery market include Creative Biolabs, AbCellera Biologics Inc., Twist Bioscience, Thermo Fisher Scientific Inc., Absci Corp., ProteoGenix, Neoncorte Bio, and others. Strategic technological collaborations are enhancing capabilities within the region.
Recent Developments:
- In June 2025, Infinimmune launched an innovative protein model based on human antibodies, revolutionizing antibody engineering.
- Antibody Solutions expanded its discovery platform in April 2025 with new services for uncovering antibodies.
- Adcentrx Therapeutics and AvantGen embarked on a partnership in February 2022, advancing antibody-drug conjugate development.
Market Insights:
- The market size analysis for 2024 indicates resilient growth patterns supported by technological advancements and collaborations.
- Strategic developments, including mergers and partnerships, are fueling progress and competitiveness in the market.
- North America stands as a pivotal region with burgeoning opportunities for stakeholders involved in antibody discovery.
- Key players continue to leverage the region's robust research framework, propelling market uptake and innovation.
Key Topics Covered:
1. Antibody Discovery Market Report Introduction
1.1. Scope of the Study
1.2. Market Segmentation
1.3. Market Assumption
2. Antibody Discovery Market Executive Summary
2.1. Market at Glance
3. Competitive Landscape
4. Regulatory Analysis
4.1. The United States
4.2. Europe
4.3. Japan
4.4. China
5. Antibody Discovery Market Key Factors Analysis
5.1. Antibody Discovery Market Drivers
5.2. Antibody Discovery Market Restraints and Challenges
5.3. Antibody Discovery Market Opportunity
6. Antibody Discovery Market Porter's Five Forces Analysis
6.1. Bargaining Power of Suppliers
6.2. Bargaining Power of Consumers
6.3. Threat of New Entrants
6.4. Threat of Substitutes
6.5. Competitive Rivalry
7. Antibody Discovery Market Assessment
7.1. By Service Type
7.2. By Antibody Type
7.3. By Application
7.4. By Source
7.5. By End-Users
7.6. By Geography
8. Antibody Discovery Market Company and Product Profiles
- Creative Biolabs
- AbCellera Biologics Inc.
- Twist Bioscience
- Thermo Fisher Scientific Inc.
- Absci Corp.
- ProteoGenix
- Neoncorte Bio
- Antibody Design Labs
- Adimab, GenScript
- Sino Biological, Inc.
- Carterra, Inc.
- WuXi AppTec
- Samsung Biologics
- Charles River Laboratories
- Lonza
- AvantGen
- Aragen Life Sciences Ltd.
- Dr. Reddy's Laboratories Ltd.
- Biointron Biological Inc.
For more information about this report visit https://www.researchandmarkets.com/r/ipbcd8
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
